NANOPARTICLE-BASED INTRANASAL DELIVERY SYSTEMS FOR BRAIN TARGETING IN DEPRESSION: MECHANISMS, THERAPEUTIC OUTCOMES, AND TRANSLATIONAL CHALLENGES
DOI:
https://doi.org/10.14450/infarma.e202623Abstract
Depression is still one of the most severe worldwide health disorders, with conventional oral antidepressant medications hampered by delayed onset, significant first-pass metabolism, low adherence, and limited brain penetration. This review critically assesses nanoparticle-based intranasal delivery options designed to address these constraints. Intranasal injection allows for direct nose-to-brain transport via the olfactory and trigeminal pathways, which bypasses the blood-brain barrier and hepatic metabolism. However, traditional intranasal formulations confront problems such as enzymatic breakdown, mucociliary clearance, and a short nasal residence period. Nanocarrier systems, which include polymeric, lipid-based, and inorganic nanoparticles, improve drug solubility, stability, mucosal retention, penetration, and controlled release. Mucoadhesive coatings like chitosan enhance residence duration and paracellular transfer.
In recent preclinical investigations, antidepressant-loaded nanoparticles have shown significant pharmacokinetic and pharmacodynamic advantages, such as higher brain bioavailability, faster start of action, and improved behavioral results. Despite these advancements, clinical translation is still limited due to safety, regulatory, manufacturing, and evaluation constraints. This review summarizes current findings, highlights significant knowledge gaps, and proposes future paths to aid in the development of therapeutically applicable nanoparticle-based intranasal antidepressants.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Chaitali Jaiswal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).
